Resources from the same session
LBA12 - Predictive value of gene-expression profiles (GEPs) and their dynamics during therapy in the NeoTRIPaPDL1 trial
Presenter: Giampaolo Bianchini
Session: Mini oral session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
120MO - Prognostic value of immune gene-expression signatures (iGES) vs tumor-infiltrating lymphocytes (TILs) in early-stage HER2+ breast cancer: A combined analysis of CALGB 40601 (C40601) and PAMELA trials
Presenter: Aranzazu Fernandez-Martinez
Session: Mini oral session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
LBA14 - Neoadjuvant giredestrant (GDC-9545) + palbociclib (palbo) vs anastrozole (A) + palbo in post-menopausal women with oestrogen receptor-positive, HER2-negative, untreated early breast cancer (ER+/HER2– eBC): Interim analysis of the randomised, open-label, phase II coopERA BC study
Presenter: Sara Hurvitz
Session: Mini oral session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
121MO - Acute toxicity associated with a 3-week versus a standard 5-week regimen for locoregional breast radiotherapy delivered in the UNICANCER HypoG-01 phase III trial
Presenter: Sofia Rivera
Session: Mini oral session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
122MO - Quality of life from the Penelope-B study on high-risk HR+/HER2- early breast cancer patients treated with endocrine therapy with or without palbociclib
Presenter: José García-Saenz
Session: Mini oral session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
123MO - BARBICAN: A randomized, phase II study to determine the contribution of ipatasertib to neoadjuvant chemotherapy plus atezolizumab in women with triple-negative breast cancer
Presenter: Peter Schmid
Session: Mini oral session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
LBA13 - Predictive impact of biomarkers on pCR and survival after de-escalated neoadjuvant T-DM1 with or without endocrine therapy (ET) vs. trastuzumab+ET in HER2+/HR+ early breast cancer: WSG ADAPT TP trial
Presenter: Nadia Harbeck
Session: Mini oral session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
Discussion LBA14, 121MO, 122MO and 123MO
Presenter: Véronique Diéras
Session: Mini oral session - Breast cancer, early stage
Resources:
Slides
Webcast